IN2013CH03939A - - Google Patents
Download PDFInfo
- Publication number
- IN2013CH03939A IN2013CH03939A IN3939CH2013A IN2013CH03939A IN 2013CH03939 A IN2013CH03939 A IN 2013CH03939A IN 3939CH2013 A IN3939CH2013 A IN 3939CH2013A IN 2013CH03939 A IN2013CH03939 A IN 2013CH03939A
- Authority
- IN
- India
- Prior art keywords
- relates
- strokes
- prevention
- preparation
- acid addition
- Prior art date
Links
- 206010051055 Deep vein thrombosis Diseases 0.000 abstract 1
- 206010047249 Venous thrombosis Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 229960000288 dabigatran etexilate Drugs 0.000 abstract 1
- KSGXQBZTULBEEQ-UHFFFAOYSA-N dabigatran etexilate Chemical class C1=CC(C(N)=NC(=O)OCCCCCC)=CC=C1NCC1=NC2=CC(C(=O)N(CCC(=O)OCC)C=3N=CC=CC=3)=CC=C2N1C KSGXQBZTULBEEQ-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002980 postoperative effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IN2014/000575 WO2015033353A2 (en) | 2013-09-03 | 2014-09-03 | Novel acid addition salts of dabigatran etexilate and process for the preparation thereof |
| IN3939CH2013 IN2013CH03939A (enrdf_load_stackoverflow) | 2013-09-03 | 2014-09-03 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3939CH2013 IN2013CH03939A (enrdf_load_stackoverflow) | 2013-09-03 | 2014-09-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013CH03939A true IN2013CH03939A (enrdf_load_stackoverflow) | 2015-09-11 |
Family
ID=52629059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3939CH2013 IN2013CH03939A (enrdf_load_stackoverflow) | 2013-09-03 | 2014-09-03 |
Country Status (2)
| Country | Link |
|---|---|
| IN (1) | IN2013CH03939A (enrdf_load_stackoverflow) |
| WO (1) | WO2015033353A2 (enrdf_load_stackoverflow) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8378113B2 (en) * | 2008-06-16 | 2013-02-19 | Boehringer Ingelheim International Gmbh | Process for the manufacture of an intermediate in the synthesis of dabigatran |
| EP2603503B1 (en) * | 2010-09-27 | 2015-08-05 | ratiopharm GmbH | Dabigatran etexilate bismesylate salt, solid state forms and process for preparation thereof |
| HUP1100244A2 (hu) * | 2011-05-11 | 2012-11-28 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Gyógyszeripari intermedierek és eljárás elõállításukra |
| WO2013124749A1 (en) * | 2012-02-20 | 2013-08-29 | Alembic Pharmaceuticals Limited | Novel polymorph of dabigatran etexilate |
-
2014
- 2014-09-03 WO PCT/IN2014/000575 patent/WO2015033353A2/en not_active Ceased
- 2014-09-03 IN IN3939CH2013 patent/IN2013CH03939A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015033353A3 (en) | 2015-06-04 |
| WO2015033353A2 (en) | 2015-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20200225A1 (ar) | مشتق كوينولين عالي النقاء وطريقة لإنتاجه | |
| PH12017500408A1 (en) | Heteroaryl compunds as btk inhibitors and uses thereof | |
| MD4650B1 (ro) | Derivaţi de chinazolină utilizaţi în tratamentul HIV | |
| AU2015207757A8 (en) | N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of SHP2 | |
| MD4800B1 (ro) | Compuşi de aminopirimidinil ca inhibitori de JAK | |
| MX2017008518A (es) | Compuestos de isoquinolina para el tratamiento de virus de inmunodeficiencia humana (vih). | |
| UA113470C2 (xx) | Піримідинові та піридинові сполуки та їх застосування | |
| MY186547A (en) | 4?-fluoro-2?-methyl substituted nucleoside derivatives | |
| MX2017014035A (es) | Formas solidas novedosas. | |
| MX2020001756A (es) | Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos. | |
| PH12018500446A1 (en) | Pyridinone dicarboxamide for use as bromodomain inhibitors | |
| MX2016005760A (es) | Inhibidores de glucogeno sintasa cinasa 3 (gsk-3). | |
| EA201692548A1 (ru) | Минеральные аминокислотные комплексы активных веществ | |
| EA201500931A1 (ru) | Производные пиридин-4-ила | |
| MX376782B (es) | Métodos de administración de composiciones de amantadina. | |
| PH12017500459A1 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
| PH12016502322A1 (en) | Compounds and methods for preventing or treating malaria | |
| IN2014MU00675A (enrdf_load_stackoverflow) | ||
| MX2015000179A (es) | Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas. | |
| MX365315B (es) | Derivados de piridina sustituidos útiles como inhibidores de c-fms quinasa. | |
| MX386902B (es) | Metodos para el tratamiento de trastornos cardiovasculares. | |
| GB2557753A (en) | Substituted aminoalkylazoles as malarial aspartic protease inhibitors | |
| EA201591449A1 (ru) | Способы получения противораковых композиций | |
| IN2013MU01290A (enrdf_load_stackoverflow) | ||
| PH12015502703A1 (en) | Pharmaceutical compositions |